X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 217,049 | 55,699 | 99,216 | 121,718 | 81,787 |
| Marketable Securities | 35,949 | 46,361 | 15,000 | N/A | N/A |
| Receivables | 573 | 1,710 | 562 | 1,152 | 747 |
| Inventories | 4,479 | 2,817 | 0 | N/A | N/A |
| TOTAL | $261,577 | $112,175 | $122,076 | $128,677 | $87,878 |
| Non-Current Assets | |||||
| PPE Net | 182 | 776 | 745 | 1,104 | 1,514 |
| Intangibles | 26,601 | 27,351 | 17,351 | 17,351 | 17,351 |
| Other Non-Current Assets | 2,101 | 6,145 | 7,086 | 8,454 | 10,433 |
| TOTAL | $28,884 | $34,272 | $25,182 | $26,909 | $29,298 |
| Total Assets | $290,461 | $146,447 | $147,258 | $155,586 | $117,176 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,315 | 795 |
| Accounts payable and accrued liabilities | 5,696 | 8,621 | 8,947 | 7,777 | 4,283 |
| Accrued Expenses | 18,603 | 23,005 | 12,816 | 12,034 | 7,870 |
| TOTAL | $25,757 | $32,877 | $22,862 | $22,324 | $14,023 |
| Non-Current Liabilities | |||||
| Long Term Debt | 76,291 | 75,425 | 54,570 | 32,304 | 33,139 |
| Deferred Revenues | 464 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,502 | 15,996 | 18,727 | 26,907 | 5,602 |
| TOTAL | $78,414 | $91,421 | $73,297 | $59,211 | $38,741 |
| Total Liabilities | $104,171 | $124,298 | $96,159 | $81,535 | $52,764 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,920 | 5,783 | 5,592 | 4,070 | 1,026 |
| Common Shares | 91 | 6 | 167 | 122 | 28 |
| Retained earnings | -594,554 | -515,355 | -477,905 | -376,738 | -282,871 |
| Other shareholders' equity | -109 | -122 | -119 | -119 | -119 |
| TOTAL | $186,290 | $22,149 | $51,099 | $74,051 | $64,412 |
| Total Liabilities And Equity | $290,461 | $146,447 | $147,258 | $155,586 | $117,176 |